Roberth Nixon Moreno Muñoz, Richard Adrián Vergara Trujillo, German Andrés Guevara Lizarazo, Patrick Junior Brett Cano, Dalila Andrea León Cuervo, Adriana Marcela Puerta Lidueñas, Mariana Sarmiento Figueroa, Michael Ortega Sierra
{"title":"无症状颈动脉粥样硬化患者的中风风险:应该用药物还是手术治疗?","authors":"Roberth Nixon Moreno Muñoz, Richard Adrián Vergara Trujillo, German Andrés Guevara Lizarazo, Patrick Junior Brett Cano, Dalila Andrea León Cuervo, Adriana Marcela Puerta Lidueñas, Mariana Sarmiento Figueroa, Michael Ortega Sierra","doi":"10.24265/horizmed.2023.v23n3.11","DOIUrl":null,"url":null,"abstract":"Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.","PeriodicalId":245951,"journal":{"name":"Horizonte Médico","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente?\",\"authors\":\"Roberth Nixon Moreno Muñoz, Richard Adrián Vergara Trujillo, German Andrés Guevara Lizarazo, Patrick Junior Brett Cano, Dalila Andrea León Cuervo, Adriana Marcela Puerta Lidueñas, Mariana Sarmiento Figueroa, Michael Ortega Sierra\",\"doi\":\"10.24265/horizmed.2023.v23n3.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.\",\"PeriodicalId\":245951,\"journal\":{\"name\":\"Horizonte Médico\",\"volume\":\"29 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Horizonte Médico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24265/horizmed.2023.v23n3.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Horizonte Médico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24265/horizmed.2023.v23n3.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
脑血管疾病仍然是世界上神经系统发病和死亡的主要原因,是造成世界上最大疾病负担的病理实体之一。颈动脉粥样硬化或狭窄是缺血性中风的潜在危险因素。这种情况的识别和严格随访对于通过初级保健和心脏代谢风险的专门治疗进行并发症的二级预防至关重要。然而,根据这种风险和/或症状的存在,明确的治疗是必要的。目前,对于无症状性颈动脉狭窄是采用药物治疗还是手术治疗存在争议。考虑到这种实体的重要性,本综述旨在分析成人无症状颈动脉粥样硬化病例缺血性卒中风险的最新证据,以及手术治疗与药物治疗的潜在益处。为此,在PubMed、ScienceDirect、Web of Science和MEDLINE数据库中检索了截至2023年的出版物。研究表明,无症状颈动脉狭窄与卒中的风险显著相关(>(约10%),即使在积极抗血小板和降脂治疗的患者中也是如此。在所有接受治疗的患者中,约80%的患者有5年生存率。然而,平均超过60%的病例发生狭窄进展,并且是显著的。另一方面,颈动脉支架置入术和动脉内膜切除术是治疗性干预措施。然而,由于中风、急性心肌梗死或任何原因导致的死亡的发生或复发,与药物治疗相比,这些手术在围手术期和术后以及术后30天内的风险更高。尽管如此,在这些相同的结果中,使用动脉内膜切除术显示出优越的长期益处。因此,关于无症状颈动脉粥样硬化或狭窄的手术治疗优于药物治疗的证据是不一致的。然而,手术治疗,特别是动脉内膜切除术,可能对同侧卒中的发生或复发以及长期死亡产生重大影响,但其围手术期和术后预后存在争议。
Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente?
Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.